Findings demonstrate that TC modulates both the structural dynamics and functional toxicity of α-synuclein, and highlight its potential as a promising chemical modulator for further investigation in PD-related protein aggregation.
Abstract
Parkinson's disease (PD) is characterized by the pathological aggregation of α-synuclein (α-syn) into β-sheet-rich fibrils, contributing to neuronal toxicity and oxidative stress. In this study, we investigated the inhibitory and disaggregating effects of Triprolidine (TC) on α-syn fibrillation through a combined experimental and computational approach. Biophysical assays, including ThT assay, DLS, and ANS assays, demonstrated that TC inhibits α-syn fibrillation in a concentration-dependent manner (IC50 ≈ 255 μM), disrupts preformed fibrils, and maintains the protein's native form. CD data further revealed that TC prevents the transition of α-syn to its toxic β-sheet-rich form and facilitates partial structural reversal during disaggregation. To elucidate the molecular mechanism of inhibition, we performed all-atom molecular dynamics (MD) simulations followed by Markov State Model (MSM) construction. The simulations revealed that TC binding remodels the conformational landscape of α-syn by stabilizing compact, disordered states and reducing the population of β-sheet-prone intermediates, particularly in the aggregation-prone NAC region. MSM analysis identified metastable states with diminished aggregation potential and reduced inter-residue contact probability, offering mechanistic insights into how TC interferes with early nucleation events. TC attenuates seeded fibrillation in a concentration-dependent manner too. Complementary cellular assays, including MTT and hemolytic assays, confirmed a significant reduction in α-syn-induced cytotoxicity upon TC treatment, with a decrease in ROS levels as confirmed by the DCFH-DA assay. Together, these findings demonstrate that TC modulates both the structural dynamics and functional toxicity of α-synuclein, and highlight its potential as a promising chemical modulator for further investigation in PD-related protein aggregation.
Heterotypic interactions with Aβ42 reshape α-syn aggregation pathways and fibril conformations, generating structurally distinct α-syn fibril populations with different neuronal seeding activities, which provide a molecular framework for understanding how cross-talk between amyloidogenic proteins may contribute to stru...
Purnopama Saha, Teshani Liyanaarachchige, Anika Alim et al.· bioRxiv· 0 citations
Insight from recent DMS studies of α-synuclein are highlighted, which have implicated membrane binding as an important contribution to its toxicity and aggregation, and experiments in different cell types reveal distinct determinants of aggregation.
Daeun Noh, Robert W. Newberry· Biochemical Society Transact...· 0 citations
The misfolding and pathological aggregation of amyloid-β (Aβ) into insoluble amyloid deposits are closely associated with Alzheimer's disease (AD). Inhibiting early Aβ assembly is a critical strategy for the development of antiamyloid therapeutics. Hesperetin (HST), a natural flavanone abundant in citrus fruits, has be...
Yu Zhang, Ye-Long Wu, Sheng-Li Zhang et al.· Journal of Physical Chemistr...· 0 citations
It is shown that thrombin, a serine protease associated with inflammatory conditions, selectively cleaves α-Synuclein at Lys6–Gly7, generating a 7–140 fragment despite the presence of multiple potential cleavage sites.
Philipp Trolese, Benedetta Fongaro, Alberto Benetollo et al.· Nature Communications· 0 citations